A randomised clinical trial to compare the AV impulse foot pump with low molecular weight Heparin in the prevention of deep vein thrombosis after total hip replacement

Completed

• Conditions: Cardiovascular diseases: Thromboembolic disease; Circulatory System; Thromboembolic disease

• Registration Number: ISRCTN17418323
• Lead Sponsor: HS R&D Regional Programme Register - Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-23
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 290

Inclusion Criteria

300 consecutive primary Total Hip Replacement patients; randomised to have either Foot Pump or LMWH until discharge.

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of deep-vein thrombosis, as determined by venography on the sixth, seventh, or eighth postoperative day.

Secondary Outcome Measures

Name	Time	Method
1. Transfusion requirements<br>2. Intraoperative blood loss<br>3. Postoperative drainage<br>4. Blood-loss index<br>5. Appearance of the site of the wound according to a subjective visual-analogue scale<br>6. Swelling of the thigh.